{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["26"],"submitter":["Bargeri S"],"pubmed_abstract":["<h4>Background</h4>Several systematic reviews (SRs) assessing the use of telemedicine for musculoskeletal conditions have been published in recent years. However, the landscape of evidence on multiple clinical outcomes remains unclear.<h4>Objective</h4>We aimed to summarize the available evidence from SRs on telemedicine for musculoskeletal disorders.<h4>Methods</h4>We conducted an umbrella review of SRs with and without meta-analysis by searching PubMed and EMBASE up to July 25, 2022, for SRs of randomized controlled trials assessing telemedicine. We collected any kind of patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs), and objective measures, including direct and indirect costs. We assessed the methodological quality with the AMSTAR 2 tool (A Measu"],"journal":["Journal of medical Internet research"],"pagination":["e50090"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10873802"],"repository":["biostudies-literature"],"pubmed_title":["Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review."],"pmcid":["PMC10873802"],"pubmed_authors":["Castellini G","Banfi G","Pennestri F","Guida S","Gianola S","Bargeri S","Vitale JA"],"additional_accession":[]},"is_claimable":false,"name":"Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review.","description":"<h4>Background</h4>Several systematic reviews (SRs) assessing the use of telemedicine for musculoskeletal conditions have been published in recent years. However, the landscape of evidence on multiple clinical outcomes remains unclear.<h4>Objective</h4>We aimed to summarize the available evidence from SRs on telemedicine for musculoskeletal disorders.<h4>Methods</h4>We conducted an umbrella review of SRs with and without meta-analysis by searching PubMed and EMBASE up to July 25, 2022, for SRs of randomized controlled trials assessing telemedicine. We collected any kind of patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs), and objective measures, including direct and indirect costs. We assessed the methodological quality with the AMSTAR 2 tool (A Measu","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2026-06-09T07:13:21.467Z","creation":"2025-04-20T04:02:50.732Z"},"accession":"S-EPMC10873802","cross_references":{"pubmed":["38306156"],"doi":["10.2196/50090"]}}